BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 29798354)

  • 21. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
    Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
    Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Variations in Serum CEA and CYFRA21-1 Levels Before and After Surgery Facilitate Prognosis of Non-small Cell Lung Cancer Patients].
    Duan X; Cui Y; Gong M; Tian F; Shi G; Wu B; Liu M; Guo J; Kong Y
    Zhongguo Fei Ai Za Zhi; 2015 Jun; 18(6):358-64. PubMed ID: 26104892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative Cyfra21-1 and SCC-Ag serum titers predict survival in patients with stage II esophageal squamous cell carcinoma.
    Cao X; Zhang L; Feng GR; Yang J; Wang RY; Li J; Zheng XM; Han YJ
    J Transl Med; 2012 Sep; 10():197. PubMed ID: 22999061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammation-based prognostic system predicts postoperative survival of esophageal carcinoma patients with normal preoperative serum carcinoembryonic antigen and squamous cell carcinoma antigen levels.
    Ma Q; Liu W; Jia R; Jiang F; Duan H; Lin P; Zhang L; Long H; Zhao H; Ma G
    World J Surg Oncol; 2016 May; 14():141. PubMed ID: 27151090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of pre-treatment CYFRA 21 - 1 and SCC-Antigen assay in primary cervical carcinoma - a preliminary report.
    Puthucode-Easwaran S; Naik R; Athavale R; Handley G; Lopes A; Godfrey K; Hatem M
    J Obstet Gynaecol; 2005 Jul; 25(5):486-8. PubMed ID: 16183586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The diagnostic significance of single or combination lung cancer-related serum biomarkers in high risk lung cancer patients].
    Ni J; Guo Z; Zhang L
    Zhonghua Nei Ke Za Zhi; 2016 Jan; 55(1):25-30. PubMed ID: 26796649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation Between Squamous Cell Carcinoma Antigen Level and the Clinicopathological Features of Early-Stage Cervical Squamous Cell Carcinoma and the Predictive Value of Squamous Cell Carcinoma Antigen Combined With Computed Tomography Scan for Lymph Node Metastasis.
    Xu D; Wang D; Wang S; Tian Y; Long Z; Ren X
    Int J Gynecol Cancer; 2017 Nov; 27(9):1935-1942. PubMed ID: 28914639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic Value and Clinical Significance of Combined Detection of Serum Markers CYFRA21-1, SCC Ag, NSE, CEA and ProGRP in Non-Small Cell Lung Carcinoma.
    Li Q; Sang S
    Clin Lab; 2020 Nov; 66(11):. PubMed ID: 33180443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor marker index based on preoperative SCC and CYFRA 21-1 is a significant prognostic factor for patients with resectable esophageal squamous cell carcinoma.
    Qiao Y; Chen C; Yue J; Yu Z
    Cancer Biomark; 2019; 25(3):243-250. PubMed ID: 31282406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of CYFRA21-1, Scc-Ag and telomerase activity in serum and pleural effusion of patients with squamous-cell lung cancer.
    Liu L; Liu B; Zhu LL; Zhang W; Li Y
    Bioanalysis; 2012 Oct; 4(19):2367-74. PubMed ID: 23088463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application Value of CYFRA21-1 Combined with NSE, CEA, and SCC-Ag in Lung Cancer.
    Fu Y; Li D; Zhu Y; Yan S; Wang X; Lian Z; Xie Q; He Z
    Clin Lab; 2024 Apr; 70(4):. PubMed ID: 38623667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer.
    Jiang ZF; Wang M; Xu JL
    Life Sci; 2018 Feb; 194():1-6. PubMed ID: 29247745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of diagnostic value of four tumor markers in bronchoalveolar lavage fluid of peripheral lung cancer.
    Li J; Chen P; Mao CM; Tang XP; Zhu LR
    Asia Pac J Clin Oncol; 2014 Jun; 10(2):141-8. PubMed ID: 23551358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervix.
    Bae SN; Namkoong SE; Jung JK; Kim CJ; Park JS; Kim JW; Lee JM; Kim SJ
    Gynecol Oncol; 1997 Mar; 64(3):418-24. PubMed ID: 9062143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positive reactions for both Cyfra21-1 and CA125 indicate worst prognosis in non-small cell lung cancer.
    Ando S; Kimura H; Iwai N; Yamamoto N; Iida T
    Anticancer Res; 2003; 23(3C):2869-74. PubMed ID: 12926125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
    Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS
    Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical values of squamous cell carcinoma antigen and carcinoembryonic antigen in patients with cervical cancer treated with concurrent chemoradiotherapy.
    Yoon SM; Shin KH; Kim JY; Seo SS; Park SY; Kang S; Cho KH
    Int J Gynecol Cancer; 2007; 17(4):872-8. PubMed ID: 17343571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The predictive value of measurement of SUVmax and SCC-antigen in patients with pretreatment of primary squamous cell carcinoma of cervix.
    Nakamura K; Okumura Y; Kodama J; Hongo A; Kanazawa S; Hiramatsu Y
    Gynecol Oncol; 2010 Oct; 119(1):81-6. PubMed ID: 20580064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum levels of squamous cell carcinoma antigen and carcinoembryonic antigen as tumor markers of vulvar cancer.
    Yamawaki T; Takeshima N; Shimizu Y; Teshima H; Hasumi K
    J Obstet Gynaecol Res; 1996 Aug; 22(4):341-6. PubMed ID: 8870416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conventional tumor markers are prognostic indicators in patients with head and neck squamous cell carcinoma.
    Kimura Y; Fujieda S; Takabayashi T; Tanaka T; Sugimoto C; Saito H
    Cancer Lett; 2000 Jul; 155(2):163-8. PubMed ID: 10822131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.